Acumen Pharmaceuticals, Inc. Common Stock
$2.65
$0.08 (+3.11%)
$2.52Day Range$2.67
Key Statistics
Market Cap
$191.64M
Shares Outstanding
72.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 1, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.55
Day High
$2.67
Day Low
$2.52
Volume
890.2K
VWAP
$2.63
Prev Close
$2.57
Transactions
--
Acc. Volume
--
About Acumen Pharmaceuticals, Inc. Common Stock
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283661 employees1210-1220 WASHINGTON STREET, NEWTON, MA, 02465617-344-4190IPO Jul 1, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001576885
- Composite FIGI
- BBG0058YJ317
- Share Class FIGI
- BBG0058YJ326
- Ticker Root
- ABOS
- SIC Code
- 2836
About Acumen Pharmaceuticals, Inc. Common Stock (ABOS) Stock
Acumen Pharmaceuticals, Inc. Common Stock (ABOS) closed the 2026-09-18 session at $2.65, up 3.11% versus the previous close (+0.08). The stock opened at $2.55 and traded between $2.52 and $2.67 during that session. Session trading volume was 890K shares. The volume-weighted average price (VWAP) is $2.63.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Acumen Pharmaceuticals, Inc. Common Stock has a market capitalization of $191.6 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ABOS is listed on the XNAS exchange. The company employs approximately 61 people. Acumen Pharmaceuticals, Inc. Common Stock is headquartered in NEWTON, MA. The recorded listing date is 2021-07-01.
On this page you can find market ABOS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.